OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $503.73 million. The enterprise value is $539.42 million.
Important Dates
The last earnings date was Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 25.07 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Current Share Class | 25.07M |
| Shares Outstanding | 25.07M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.99% |
| Owned by Insiders (%) | 5.16% |
| Owned by Institutions (%) | 69.61% |
| Float | 16.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.12 |
| Forward PS | 1.90 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.66, with a Debt / Equity ratio of 0.30.
| Current Ratio | 6.66 |
| Quick Ratio | 3.21 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.26 |
Financial Efficiency
Return on equity (ROE) is -11.49% and return on invested capital (ROIC) is -4.84%.
| Return on Equity (ROE) | -11.49% |
| Return on Assets (ROA) | -4.38% |
| Return on Invested Capital (ROIC) | -4.84% |
| Return on Capital Employed (ROCE) | -7.05% |
| Revenue Per Employee | $392,763 |
| Profits Per Employee | -$74,306 |
| Employee Count | 562 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 0.52 |
Taxes
| Income Tax | -1.31M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.07% in the last 52 weeks. The beta is 1.12, so OrthoPediatrics's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -22.07% |
| 50-Day Moving Average | 21.30 |
| 200-Day Moving Average | 23.23 |
| Relative Strength Index (RSI) | 45.36 |
| Average Volume (20 Days) | 195,878 |
Short Selling Information
The latest short interest is 1.16 million, so 4.64% of the outstanding shares have been sold short.
| Short Interest | 1.16M |
| Short Previous Month | 1.12M |
| Short % of Shares Out | 4.64% |
| Short % of Float | 6.89% |
| Short Ratio (days to cover) | 8.09 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $220.73 million and -$41.76 million in losses. Loss per share was -$1.80.
| Revenue | 220.73M |
| Gross Profit | 157.91M |
| Operating Income | -32.76M |
| Pretax Income | -27.03M |
| Net Income | -41.76M |
| EBITDA | -13.27M |
| EBIT | -32.76M |
| Loss Per Share | -$1.80 |
Full Income StatementBalance Sheet
The company has $70.15 million in cash and $105.84 million in debt, giving a net cash position of -$35.69 million or -$1.42 per share.
| Cash & Cash Equivalents | 70.15M |
| Total Debt | 105.84M |
| Net Cash | -35.69M |
| Net Cash Per Share | -$1.42 |
| Equity (Book Value) | 355.51M |
| Book Value Per Share | 14.18 |
| Working Capital | 219.04M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.88 million and capital expenditures -$8.79 million, giving a free cash flow of -$37.68 million.
| Operating Cash Flow | -28.88M |
| Capital Expenditures | -8.79M |
| Free Cash Flow | -37.68M |
| FCF Per Share | -$1.50 |
Full Cash Flow StatementMargins
Gross margin is 71.54%, with operating and profit margins of -14.84% and -18.92%.
| Gross Margin | 71.54% |
| Operating Margin | -14.84% |
| Pretax Margin | -19.51% |
| Profit Margin | -18.92% |
| EBITDA Margin | -6.01% |
| EBIT Margin | -14.84% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -8.29% |
| FCF Yield | -7.48% |
Analyst Forecast
The average price target for OrthoPediatrics is $34.14, which is 69.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.14 |
| Price Target Difference | 69.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 2.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.55 |
| Piotroski F-Score | 3 |